World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 3 August 2015
Main ID:  NCT00152737
Date of registration: 08/09/2005
Prospective Registration: No
Primary sponsor: University Hospital, Angers
Public title: Objective Evaluation of Proximal Ischemia
Scientific title: Effet Des Gestes de Revascularisation à l'étage Proximal
Date of first enrolment: March 2004
Target sample size: 165
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT00152737
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     jean louis Saumet, MD PhD
Address: 
Telephone:
Email:
Affiliation:  University Hospital in Angers
Name:     Bernard Enon, MD
Address: 
Telephone:
Email:
Affiliation:  University Hospital in Angers
Name:     Pierre Abraham, MD PhD
Address: 
Telephone:
Email:
Affiliation:  University Hospital in Angers
Key inclusion & exclusion criteria

Inclusion Criteria:

- protocol 1 - 3 stage 2 claudication

- Protocols 2 & 3 : Indication for surgery

- protocol 4 : Patent aorto bio femoral bypass for more than 4 months

- Ability to perform a treadmill test

Exclusion Criteria:

- Stage 4 LEAD

- Aortic aneurysm

- Acute coronary syndrom

- claudication of documented non vascular origin (for protocols 1-3 only)



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Peripheral Vascular Diseases
Intermittent Claudication
Intervention(s)
Procedure: Exercise test with Transcutaneous oxygene pressure
Procedure: Ankle and arm pressure values
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
PHRC 03-01
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Sanofi-Synthelabo
Société Française de Médecine Vasculaire
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history